I am happy to respond to Dr Hustead's inquiry regarding our article.
Dr Hustead is correct with her assessment of the mistake that was made on page 1139, left column, first complete paragraph, last sentence about the eyes that were treated with dorzolamide hydrochloride. This sentence should have read as follows: "The mean±SD CCT of the 46 eyes being treated with dorzolamide (0.560±0.025) was significantly greater than that of the 28 eyes not receiving dorzolamide (0.551±0.020)." Although the CCT was found to be statistically significantly greater among eyes with glaucoma receiving dorzolamide in our study, the clinical significance of this difference is unknown. We use dorozolamide cautiously in eyes with compromised corneas.
Herndon LW. Central Corneal Thickness—Reply. Arch Ophthalmol. 1998;116(9):1263. doi: